KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Exact Sciences (EXAS) Revenue (2016 - 2025)

Exact Sciences (EXAS) has disclosed Revenue for 16 consecutive years, with $878.4 million as the latest value for Q4 2025.

  • Quarterly Revenue rose 23.12% to $878.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $3.2 billion through Dec 2025, up 17.69% year-over-year, with the annual reading at $3.2 billion for FY2025, 17.69% up from the prior year.
  • Revenue for Q4 2025 was $878.4 million at Exact Sciences, up from $850.7 million in the prior quarter.
  • The five-year high for Revenue was $878.4 million in Q4 2025, with the low at $402.1 million in Q1 2021.
  • Average Revenue over 5 years is $617.8 million, with a median of $625.2 million recorded in 2023.
  • Peak annual rise in Revenue hit 61.72% in 2021, while the deepest fall reached 1.6% in 2021.
  • Over 5 years, Revenue stood at $473.8 million in 2021, then rose by 16.71% to $553.0 million in 2022, then rose by 16.98% to $646.9 million in 2023, then rose by 10.29% to $713.4 million in 2024, then grew by 23.12% to $878.4 million in 2025.
  • According to Business Quant data, Revenue over the past three periods came in at $878.4 million, $850.7 million, and $811.1 million for Q4 2025, Q3 2025, and Q2 2025 respectively.